Streetbeat News

Stock Prices

AXON

ET

PRGO

Insiders have recently purchased shares in Energy Transfer, Axon Enterprise, and Perrigo Company, signaling confidence in these companies. Energy Transfer posted downbeat quarterly results, Axon reported better-than-expected Q1 results, and Perrigo received FDA approval for nicotine coated mint lozenges.

Portfolio Pulse from Lisa Levin

May 26, 2023 | 1:16 pm

CAN

Canaan Inc reported a Q1 FY23 revenue decline of 72.6% YoY to $55.2 million, missing the consensus of $62.1 million. Adjusted EPS loss of $0.43 missed the consensus loss of $0.21. Canaan expects Q2 revenue of $72 million vs. consensus of $77.4 million. CAN shares traded lower by 6.20% premarket.

Portfolio Pulse from Anusuya Lahiri

May 26, 2023 | 1:14 pm

LEGN

Legend Biotech Corp has filed for a stock shelf of 8.83 million ordinary shares, represented by 4.42 million American Depositary Shares (ADS), to be sold by existing shareholders, according to a SEC filing.

Portfolio Pulse from Happy Mohamed

May 26, 2023 | 1:13 pm

GPS

ULTA

12 consumer discretionary stocks experienced significant price movements in Friday's pre-market session, with Gap and Ulta Beauty reporting Q1 earnings. Gainers included Gap, Shift Techs, Golden Sun Education, Smart Share Glb, Gaotu Techedu, and Xcel Brands. Losers were Lottery.com, EpicQuest Education Group, Grove Collaborative Hldgs, Ulta Beauty, Connexa Sports Techs, and Selina Hospitality.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 1:10 pm

MRVL

WDAY

In Friday's pre-market session, 12 IT stocks experienced significant movement. Marvell Tech and Workday reported Q1 earnings, while other stocks saw gains and losses.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 1:09 pm

EFTR

eFFECTOR Therapeutics announced a $7.5M registered direct offering priced at-the-market. The company plans to use the proceeds for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 1:08 pm

CGEM

In the last quarter, 4 analysts have given bullish ratings for Cullinan Oncology (NASDAQ:CGEM) with an average price target of $49.5, compared to its current price of $9.56. This represents a 1.0% decrease from the previous average price target of $50.00.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 1:05 pm

MU

Over the past 3 months, 13 analysts have published their opinion on Micron Technology (NASDAQ:MU) stock, with an average 12-month price target of $76.23, up 20.62% from the previous average of $63.20. The ratings include 4 bullish, 7 somewhat bullish, and 2 indifferent.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 1:04 pm

RDFN

Analysts have provided ratings for Redfin (NASDAQ:RDFN) within the last quarter, with an average price target of $8.67, implying a downside compared to the current price of $9.55. The average price target has increased by 13.78% over the past month.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 1:03 pm

MRVL

In the last quarter, Marvell Tech (NASDAQ:MRVL) received 13 bullish, 16 somewhat bullish, and 1 indifferent analyst ratings. The company's average 12-month price target is $63.33, up 9.74% from the previous average of $57.71.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 1:03 pm